Cardiovascular Systems is a medical technology company. Co. has developed a patented orbital atherectomy systems (OAS) for both peripheral and coronary clinical applications. Co.'s peripheral artery disease products are catheter-based platforms capable of treating a range of plaque types in leg arteries both above and below the knee, including calcified plaque, and address various limitations associated with other existing surgical, catheter and pharmacological treatment alternatives. Co.'s coronary artery disease (CAD) product, the Diamondback 360 Coronary OAS, is a catheter-based platform designed to facilitate stent delivery in patients with CAD. We show 52 historical shares outstanding datapoints in our CSII shares outstanding history coverage, used to compute CSII market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing CSII market cap history over the course of time is important for investors
interested in comparing CSII's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of CSII versus a peer is one thing; comparing
CSII market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like CSII can fluctuate over the course of history.
With this page we aim to empower investors researching CSII by allowing them to research the CSII market cap history. |
Free CSII Email Alerts:
Video: The Importance of Market Cap
